Editor

Latest stories

More stories

  • NIH Grant Sparks Next Generation Cancer Treatment at Corewell Health

    A New Dawn in Cancer Treatment with Dynamic Proton Beam Therapy In recent years, the field of cancer treatment has experienced some pretty remarkable advances. One such advancement is the evolution of proton beam therapy, particularly the innovative dynamic SPArc (Spot-Scanning Proton Arc) system that is poised to revolutionize how we approach radiation treatment. The […] More

  • Trending

    Unlocking the hidden economic challenges of cancer care

    Introduction: The Hidden Economic Side of Cancer Treatment Cancer is often viewed solely as a medical challenge. However, behind every diagnosis lies a tangled web of non‐medical economic consequences that ripple through families and communities. In low‐ and middle‐income countries, especially in places like Bangladesh, the financial toll of cancer extends far beyond medical bills. […] More

  • Rethinking Cardiac Care for Breast Cancer Survivors

    The Digital Gatekeepers of Healthcare: Striking a Balance Between Access and Security In today’s interconnected world, healthcare information is not just about the latest advances in modern medicine, alternative therapies, nutritional advice, disease conditions, or fitness trends—it’s also about ensuring that this critical data remains secure. As our reliance on online platforms grows, so does […] More

  • Shorter Chemo Duration Boosts Patient Quality of Life in Advanced Urothelial Cancer

    Reevaluating Chemotherapy Duration in Advanced Urothelial Cancer The recent DISCUS trial has sparked a reexamination of traditional chemotherapy protocols for advanced urothelial cancer. With evidence now suggesting that a shorter duration of platinum‐based chemotherapy can considerably improve patient-reported outcomes while preserving treatment efficacy, the oncology community is now taking a closer look at how treatment […] More

  • Nivolumab Administration Routes Offer Equivalent Outcomes in ccRCC Treatment

    An Unexpected Encounter with Website Security Measures In our increasingly digital world, even sites dedicated to healthcare information are not immune to the tricky parts of online security. Recently, I encountered a website message that left me both frustrated and reflective—a message that read: “Please enable cookies. Sorry, you have been blocked.” This seemingly technical […] More

  • Bridging the Gap between Cancer Treatment and Lifelong Wellness

    Enhancing Communication for Cancer Survivors In recent decades, the fight against cancer has seen remarkable progress, resulting in improved survival rates. Today, more than 18 million Americans have lived through a cancer diagnosis, with projections suggesting this number will rise to about 26 million by 2040. However, finishing treatment does not signify the end of […] More

  • Bristol Myers Squibb Breakfree One Study Unleashes New Possibilities in Cd19 Therapy

    Bristol Myers Squibb’s Bold Foray into Autoimmune Cell Therapy Bristol Myers Squibb’s recent presentation at ACR Convergence 2025 has sparked considerable discussion among medical professionals and researchers alike. The company’s early-stage Phase 1 Breakfree-1 study involving CD19 NEX-T™ CAR T cell therapy in chronic autoimmune diseases signals that cell therapy—traditionally used for blood cancers—may soon […] More

  • Transforming Outpatient BCE Safety Through Teamwork and Expertise

    Opinion Editorial: Strengthening Outpatient BCE Safety Through Multidisciplinary Oversight The recent expansion of bispecific T‑cell engager (BCE) therapies to treat not only hematologic malignancies but also solid tumors has sparked both excitement and concern across the oncology community. Over the past year, a Michigan-based community oncology practice has shown that implementing a robust, multidisciplinary approach […] More

  • Paraneoplastic Neurologic Signals Hint at Underlying Testicular Germ Cell Tumor

    Early Warning Signs: Understanding Paraneoplastic Neurologic Syndromes in Testicular Germ Cell Tumors The recent study highlighting that patients with testicular germ cell tumors (TGCTs) often show signs of paraneoplastic neurologic syndromes (PNSs) before their cancer diagnosis presents a thought-provoking look into the tangled issues connecting neurology and oncology. As an editor at an online healthcare […] More

Load More
Congratulations. You've reached the end of the internet.